Home NDC 30727-300 B-PLEX 100
Product NDC 30727-300
11-digit product format 307270300
Labeler code 30727
Product ID 30727-300_b5a5fde8-7e4f-5e84-e053-2995a90a55e0
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Thiamine Hydrochloride, Riboflavin 5-Phosphate Sodium, Pyridoxine Hydrochloride, Dexpanthenol, Niacinamide
Dosage form INJECTION, SOLUTION
Route INTRAMUSCULAR; INTRAVENOUS
Labeler Merit Pharmaceutical
Marketing category UNAPPROVED DRUG OTHER
Marketing start 2012-01-01
Marketing end 0000-00-00
Substance THIAMINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; PYRIDOXINE HYDROCHLORIDE; DEXPANTHENOL; NIACINAMIDE
Active strength 100 mg/mL; mg/mL; mg/mL; mg/mL; mg/mL
Pharmacologic classes Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 38 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 30727-300-80 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 30727-300-80 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 30727-300-80 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 30727-300-80 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 30727-300-80 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 30727-300-80 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 30727-300-80 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 30727-300-80 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 30727-300-80 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 30727-300-80 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 30727-300-80 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 30727-300-80 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 30727-300-80 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 30727-300-80 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 30727-300-80 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 30727-300-80 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 30727-300-80 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 30727-300-80 I Inactivated by FDA bd6a592717d7…303034d00443…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 30727-300-80 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Dexpanthenol ACTIVE INGREDIENT 1O6C93RI7Z B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Niacinamide ACTIVE INGREDIENT 25X51I8RD4 B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Pyridoxine Hydrochloride ACTIVE INGREDIENT 68Y4CF58BV B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 RIBOFLAVIN 5'-PHOSPHATE SODIUM ACTIVE INGREDIENT 20RD1DZH99 B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Thiamine Hydrochloride ACTIVE INGREDIENT M572600E5P B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Dexpanthenol ACTIVE MOIETY 1O6C93RI7Z B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Niacinamide ACTIVE MOIETY 25X51I8RD4 B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Pyridoxine ACTIVE MOIETY KV2JZ1BI6Z B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 RIBOFLAVIN ACTIVE MOIETY TLM2976OFR B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Thiamine Ion ACTIVE MOIETY 4ABT0J945J B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Benzyl Alcohol INACTIVE INGREDIENT LKG8494WBH B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Hydrochloric Acid INACTIVE INGREDIENT QTT17582CB B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Sodium Hydroxide INACTIVE INGREDIENT 55X04QC32I B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1 Water INACTIVE INGREDIENT 059QF0KO0R B-PLEX 100 (THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, NIACINAMIDE) INJECTION, SOLUTION [MERIT PHARMACEUTICAL] 1
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 30727-300-80 30727030080 1 VIAL, MULTI-DOSE in 1 CARTON (30727-300-80) > 30 mL in 1 VIAL, MULTI-DOSE 2012-01-01 0000-00-00 No No Current